DiaSorin S.p.A. (LON:0GZX)
78.00
-0.66 (-0.84%)
At close: Oct 27, 2025
DiaSorin Revenue
DiaSorin had revenue of 306.27M EUR in the quarter ending June 30, 2025, with 2.02% growth. This brings the company's revenue in the last twelve months to 1.22B, up 4.69% year-over-year. In the year 2024, DiaSorin had annual revenue of 1.19B with 3.24% growth.
Revenue (ttm)
1.22B EUR
Revenue Growth
+4.69%
P/S Ratio
3.49
Revenue / Employee
367.44K EUR
Employees
3,308
Market Cap
3.63B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
| Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
| Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
| Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
| Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |